|Articles|May 24, 2022
MMS Holdings Selects THREAD as Partner
Collaboration will utilize THREAD's DCT technology.
Advertisement
MMS Holdings Inc. (MMS) announced a collaboration with THREAD® as its partner of choice for its decentralized clinical trial platform (DCT) and DCT-enabled services.
This partnership solidifies MMS as a full-service DCT provider, from electronic data capture (EDC) through completion of the DCT.
Read more about the partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
